Sign Up Today and Learn More About OM1 Stock
Invest in or calculate the value of your shares in OM1 or other pre-IPO companies through EquityZen's platform.
OM1 Stock
Healthcare Technology Company
OM1 (formerly Better Outcomes) is a digital health company focused on the measurement, comparison, and prediction of treatment outcomes.
About OM1 Stock
Founded
2015
Headquarters
Boston, MA, US
Notable Investor
General Catalyst Partners
Total Funding
176M
Industries
OM1 (formerly Better Outcomes) is a digital health company focused on the measurement, comparison, and prediction of treatment outcomes. OM1 believes that a value-based healthcare system requires a much more complete view of patient outcomes than has been available until now. OM1 offers a real-world evidence platform, clinical registries and AI technologies that aim to help clients with their research, to measure and benchmark health outcomes and to personalize patient care.Â
OM1 was founded in 2015 by Richard Gliklich and is headquartered in Boston, Massachusetts. Notable investors include General Catalyst, Polaris Partners, and Scale Venture Partners.
OM1 Press Mentions
Stay in the know about the latest news on OM1
OM1 Launches Three New Products Powered by Patented AI Platform to Expedite Delivery of Personalized Medicine
businesswire • May 06, 2024
OM1 Aims To Improve Healthcare Outcomes Through Big Data And AI
forbes • Nov 22, 2022
OM1 LAUNCHES A NEW ESTIMATION MODEL FOR THE EXPANDED DISABILITY STATUS SCORE (EDSS) FOR MULTIPLE SCLEROSIS PATIENTS
prnewswire • Jun 25, 2022
OM1 scores $85M to build out clinical data network, AI analytics models
fiercehealthcare • Jul 20, 2021
AI startup OM1 bags $85M as Mass. VC deal activity reaches new high
bizjournals • Jul 16, 2021
Investors in OM1
Discover investors in OM1 stock and explore their portfolio companies
OM1 Management
Leadership team at OM1
Chief Executive Officer
Rich Gliklich
Chief Financial Officer
Dennis Reilly
Join now and verify your accreditation status to gain access to:
- OM1 current valuation
- OM1 stock price
- Available deals in OM1 and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in OM1 stock?
Accredited investors can buy pre-IPO stock in companies like OM1 through EquityZen funds. These investments are made available by existing OM1 shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell OM1 stock?
Shareholders can sell their OM1 stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
